Moleculin Biotech, Inc.

MBRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 17 employees
506
SEC Filings
$0.5669
Close 2026-09-24
17
Employees

Business Summary

Moleculin Biotech, Inc. is a late-stage pharmaceutical development company focused on hard-to-treat cancers and viruses. Its lead candidate, Annamycin (naxtarubicin), is a next-generation anthracycline currently in a pivotal Phase 3 MIRACLE trial for relapsed/refractory acute myeloid leukemia (AML). The company also develops WP1066 portfolio compounds targeting p-STAT3 and WP1122 portfolio glycolysis inhibitors. All three core technologies are substantially based on discoveries licensed from MD Anderson Cancer Center.

Latest Stock Quote

MBRX 2026-09-24 $0.5669 O:$0.52 H:$0.57 L:$0.51 Vol:0.5M VWAP:$0.5407
origin leaf: null

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-182025-12-310001437749-26-008841EDGAR92K words
2025-03-212024-12-310001437749-25-008751EDGAR79K words
2024-03-222023-12-310001437749-24-009044EDGAR79K words
2023-03-222022-12-310001437749-23-007537EDGAR76K words
2022-03-242021-12-310001437749-22-007103EDGAR—
2021-03-242020-12-310001437749-21-006940EDGAR—
2020-03-192019-12-310001659617-20-000066EDGAR—
2019-02-212018-12-310001659617-19-000018EDGAR—
2018-03-282017-12-310001659617-18-000027EDGAR—
2017-04-032016-12-310001144204-17-018352EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001437749-26-027688EDGAR20K words
2025-11-132025-09-300001437749-25-034839EDGAR27K words
2025-08-122025-06-300001437749-25-026225EDGAR21K words
2025-05-132025-03-310001437749-25-016466EDGAR15K words
2024-11-082024-09-300001437749-24-034236EDGAR19K words
2024-08-132024-06-300001437749-24-026367EDGAR14K words
2024-05-102024-03-310001437749-24-016031EDGAR12K words
2023-11-132023-09-300001437749-23-031391EDGAR19K words
2023-08-102023-06-300001437749-23-023021EDGAR17K words
2023-05-102023-03-310001437749-23-013582EDGAR14K words
2022-11-102022-09-300001437749-22-026888EDGAR—
2022-08-122022-06-300001437749-22-020389EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-290001437749-26-031419EDGAR—
2026-09-280001437749-26-031280EDGAR1K words
2026-09-250001437749-26-031199EDGAR1K words
2026-09-230001437749-26-031005EDGAR1K words
2026-09-180001437749-26-030757EDGAR1K words
2026-09-140001437749-26-030315EDGAR1K words
2026-08-310001437749-26-029336EDGAR0K words
2026-08-140001437749-26-027835EDGAR3K words
2026-08-030001437749-26-025474EDGAR20K words
2026-07-310001437749-26-025167EDGAR1K words

506 total filings indexed. 474 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

relapsed/refractory-acute-myeloid-leukemia-(aml) soft-tissue-sarcoma-with-lung-metastases glioblastoma-(gbm) pancreatic-cancer oncology-(broad-anthracycline-market) antiviral

Company Identity

CIK0001659617
TickerMBRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.moleculin.com
Listed2016-06-02

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 08d4187d0a44d8cc0b72958578977c2da937d0f7c3ab45760a0c9014a048a9e4
parent: a7423df5137ede9416294e8d3c4c916a4c91c467e0a4364fe38119e0e92830ed
content hash: edf2273b8ea7708e38902578c40099578d39748f64479b9067d194092d8399ad
signed: 2026-09-29T19:02:07.309Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MBRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MBRX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MBRX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.